Vor Biopharma Inc (NASDAQ:VOR) shares, rose in value on Thursday, July 10, with the stock price down by -9.06% to the previous day’s close as strong demand from buyers drove the stock to $2.31.
Actively observing the price movement in the last trading, the stock closed the session at $2.54, falling within a range of $2.25 and $2.63. The value of beta (5-year monthly) was -0.514. Referring to stock’s 52-week performance, its high was $3.29, and the low was $0.13. On the whole, VOR has fluctuated by 936.34% over the past month.
With the market capitalization of Vor Biopharma Inc currently standing at about $288.66 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-14.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that VOR’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the price of VOR currently trading nearly 120.70% and 288.72% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 74.74, while the 7-day volatility ratio is showing 34.03% which for the 30-day chart, stands at 36.67%. Furthermore, Vor Biopharma Inc (VOR)’s beta value is 2.04.
A comparison of Vor Biopharma Inc (VOR) with its peers suggests the former has fared considerably weaker in the market. VOR showed an intraday change of -9.06% in last session, and over the past year, it grew by 108.11%%.
Data on historical trading for Vor Biopharma Inc (NASDAQ:VOR) indicates that the trading volumes over the past 10 days have averaged 59.94 and over the past 3 months, they’ve averaged 16.90 million. According to company’s latest data on outstanding shares, there are 124.85 million shares outstanding.
Nearly 38.49% of Vor Biopharma Inc’s shares belong to company insiders and institutional investors own 42.26% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 3.22 million shares as on 2025-06-13, resulting in a short ratio of 0.79. According to the data, the short interest in Vor Biopharma Inc (VOR) stood at 707.00 of shares outstanding as of 2025-06-13; the number of short shares registered in 2025-05-15 reached 2.76 million. The stock has risen by 154.94% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the VOR stock heading into the next quarter.
